In clinical trials, DUPIXENT reduced nasal congestion and nasal polyp size in adult patients with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP) and improved the ability to smell.

In clinical studies, utilizing a symptom measurement tool, adults taking DUPIXENT saw an improved ability to smell in as little as 3 days.